Laaksonen Maarit A, Sirkiä Carlos, Knekt Paul, Lindfors Olavi
Department of Health, Functional Capacity and Welfare, National Institute for Health and Welfare (THL) Helsinki, Finland.
Department of Health, Functional Capacity and Welfare, National Institute for Health and Welfare (THL) Helsinki, Finland ; Biomedicum Helsinki Helsinki, Finland ; Social Insurance Institution Helsinki, Finland.
Brain Behav. 2014 Jul;4(4):495-503. doi: 10.1002/brb3.190. Epub 2014 May 9.
Identification of pretreatment patient characteristics predictive of psychotherapy outcome could help to guide treatment choices. This study evaluates patients' initial level of immature defense style as a predictor of the outcome of short-term versus long-term psychotherapy.
In the Helsinki Psychotherapy Study, 326 adult outpatients with mood or anxiety disorder were randomized to individual short-term (psychodynamic or solution-focused) or long-term (psychodynamic) psychotherapy. Their defense style was assessed at baseline using the 88-item Defense Style Questionnaire and classified as low or high around the median value of the respective score. Both specific (Beck Depression Inventory [BDI], Hamilton Depression Rating Scale [HDRS], Symptom Check List Anxiety Scale [SCL-90-Anx], Hamilton Anxiety Rating Scale [HARS]) and global (Symptom Check List Global Severity Index [SCL-90-GSI], Global Assessment of Functioning Scale [GAF]) psychiatric symptoms were measured at baseline and 3-7 times during a 3-year follow-up.
Patients with high use of immature defense style experienced greater symptom reduction in long-term than in short-term psychotherapy by the end of the 3-year follow-up (50% vs. 34%). Patients with low use of immature defense style experienced faster symptom reduction in short-term than in long-term psychotherapy during the first year of follow-up (34% vs. 19%).
Knowledge of patients' initial level of immature defense style may potentially be utilized in tailoring treatments. Further research on defense styles as outcome predictors in psychotherapies of different types is needed.
识别能够预测心理治疗效果的治疗前患者特征,有助于指导治疗方案的选择。本研究评估患者不成熟防御方式的初始水平,以此作为短期与长期心理治疗效果的预测指标。
在赫尔辛基心理治疗研究中,326名患有情绪或焦虑障碍的成年门诊患者被随机分配接受个体短期(心理动力或聚焦解决)或长期(心理动力)心理治疗。使用88项防御方式问卷在基线时评估他们的防御方式,并根据各自分数的中位数分为低或高两类。在基线时以及3年随访期间的3至7次测量中,测量特定(贝克抑郁量表[BDI]、汉密尔顿抑郁评定量表[HDRS]、症状自评量表焦虑分量表[SCL - 90 - Anx]、汉密尔顿焦虑量表[HARS])和整体(症状自评量表总体严重程度指数[SCL - 90 - GSI]、功能总体评定量表[GAF])精神症状。
在3年随访结束时,高度使用不成熟防御方式的患者在长期心理治疗中比在短期心理治疗中症状减轻更明显(50%对34%)。低度使用不成熟防御方式的患者在随访的第一年中,短期心理治疗比长期心理治疗症状减轻更快(34%对19%)。
了解患者不成熟防御方式的初始水平可能有助于量身定制治疗方案。需要进一步研究防御方式作为不同类型心理治疗效果预测指标的情况。